GB202018901D0 - New pharmaceutical composition - Google Patents

New pharmaceutical composition

Info

Publication number
GB202018901D0
GB202018901D0 GBGB2018901.5A GB202018901A GB202018901D0 GB 202018901 D0 GB202018901 D0 GB 202018901D0 GB 202018901 A GB202018901 A GB 202018901A GB 202018901 D0 GB202018901 D0 GB 202018901D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
new pharmaceutical
new
composition
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2018901.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orexo AB
Original Assignee
Orexo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo AB filed Critical Orexo AB
Priority to GBGB2018901.5A priority Critical patent/GB202018901D0/en
Publication of GB202018901D0 publication Critical patent/GB202018901D0/en
Priority to AU2021276611A priority patent/AU2021276611A1/en
Priority to MX2022014216A priority patent/MX2022014216A/en
Priority to HUE21728101A priority patent/HUE060573T2/en
Priority to PT217281013T priority patent/PT3962455T/en
Priority to SI202130007T priority patent/SI3962455T1/en
Priority to PE2022002543A priority patent/PE20230382A1/en
Priority to CN202180036365.8A priority patent/CN115666513A/en
Priority to DK21728101.3T priority patent/DK3962455T3/en
Priority to CA3178769A priority patent/CA3178769A1/en
Priority to EP21728101.3A priority patent/EP3962455B1/en
Priority to EP22191078.9A priority patent/EP4154866A1/en
Priority to ES21728101T priority patent/ES2929818T3/en
Priority to HRP20221361TT priority patent/HRP20221361T1/en
Priority to BR112022023307A priority patent/BR112022023307A2/en
Priority to MDE20220282T priority patent/MD3962455T2/en
Priority to JP2022570692A priority patent/JP2023526098A/en
Priority to PL21728101.3T priority patent/PL3962455T3/en
Priority to KR1020227040261A priority patent/KR20230012502A/en
Priority to LTEPPCT/GB2021/051191T priority patent/LT3962455T/en
Priority to IL297658A priority patent/IL297658A/en
Priority to PCT/GB2021/051191 priority patent/WO2021234366A1/en
Priority to RS20221016A priority patent/RS63725B1/en
Priority to US17/540,929 priority patent/US11737980B2/en
Priority to CONC2022/0015183A priority patent/CO2022015183A2/en
Priority to CL2022002979A priority patent/CL2022002979A1/en
Priority to US18/345,770 priority patent/US20240024244A1/en
Ceased legal-status Critical Current

Links

GBGB2018901.5A 2020-05-18 2020-12-01 New pharmaceutical composition Ceased GB202018901D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GBGB2018901.5A GB202018901D0 (en) 2020-12-01 2020-12-01 New pharmaceutical composition
RS20221016A RS63725B1 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
ES21728101T ES2929818T3 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug administration
BR112022023307A BR112022023307A2 (en) 2020-05-18 2021-05-18 PHARMACEUTICAL COMPOSITION FOR DELIVERY OF DRUGS
HUE21728101A HUE060573T2 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
PT217281013T PT3962455T (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
SI202130007T SI3962455T1 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
PE2022002543A PE20230382A1 (en) 2020-05-18 2021-05-18 NEW PHARMACEUTICAL COMPOSITION FOR DRUG ADMINISTRATION
CN202180036365.8A CN115666513A (en) 2020-05-18 2021-05-18 Novel pharmaceutical compositions for drug delivery
DK21728101.3T DK3962455T3 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
CA3178769A CA3178769A1 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
EP21728101.3A EP3962455B1 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
EP22191078.9A EP4154866A1 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
AU2021276611A AU2021276611A1 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
HRP20221361TT HRP20221361T1 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
MX2022014216A MX2022014216A (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery.
MDE20220282T MD3962455T2 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
JP2022570692A JP2023526098A (en) 2020-05-18 2021-05-18 New pharmaceutical compositions for drug delivery
PL21728101.3T PL3962455T3 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
KR1020227040261A KR20230012502A (en) 2020-05-18 2021-05-18 Novel pharmaceutical compositions for drug delivery
LTEPPCT/GB2021/051191T LT3962455T (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
IL297658A IL297658A (en) 2020-05-18 2021-05-18 Pharmaceutical composition for drug delivery
PCT/GB2021/051191 WO2021234366A1 (en) 2020-05-18 2021-05-18 New pharmaceutical composition for drug delivery
US17/540,929 US11737980B2 (en) 2020-05-18 2021-12-02 Pharmaceutical composition for drug delivery
CONC2022/0015183A CO2022015183A2 (en) 2020-05-18 2022-10-25 New pharmaceutical composition for drug administration
CL2022002979A CL2022002979A1 (en) 2020-05-18 2022-10-26 New pharmaceutical composition for drug administration
US18/345,770 US20240024244A1 (en) 2020-05-18 2023-06-30 New pharmaceutical composition for drug delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2018901.5A GB202018901D0 (en) 2020-12-01 2020-12-01 New pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB202018901D0 true GB202018901D0 (en) 2021-01-13

Family

ID=74099900

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2018901.5A Ceased GB202018901D0 (en) 2020-05-18 2020-12-01 New pharmaceutical composition

Country Status (1)

Country Link
GB (1) GB202018901D0 (en)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702362A (en) 1995-05-26 1997-12-30 Bayer Aktiengesellschaft Nasal applicator
US6398074B1 (en) 1998-03-10 2002-06-04 Valois S.A. Reservoir, reservoir filling method and device for dispensing fluid contained in the reservoir
US20050001411A1 (en) 2001-09-06 2005-01-06 Christian Theiss Method for the determination of parameters of a seat passenger
US6938798B2 (en) 2000-12-08 2005-09-06 Tebro S.A. Fluid or powdery product dispensing device
US7722566B2 (en) 2003-10-09 2010-05-25 Shin Nippon Biomedical Laboratories, Ltd. Device to deliver a powdery medicine into nasal cavity
WO2010142696A1 (en) 2009-06-11 2010-12-16 Charité - Universitätsmedizin Berlin Use of opioid receptor antagonists for acute treatment of paraphilic arousal states
US20110045088A1 (en) 2009-07-31 2011-02-24 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2014004400A2 (en) 2012-06-28 2014-01-03 The Governt. Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services Nasal dry powder delivery system for vaccines and other treatment agents
US9724713B2 (en) 2013-07-05 2017-08-08 Aptar France Sas Fluid or powdery product dispensing device
US20180092839A1 (en) 2016-10-03 2018-04-05 Lance L. Gooberman Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders
WO2019038756A1 (en) 2017-08-20 2019-02-28 Solubest Ltd. Dry powder compositions for intranasal delivery

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702362A (en) 1995-05-26 1997-12-30 Bayer Aktiengesellschaft Nasal applicator
US6398074B1 (en) 1998-03-10 2002-06-04 Valois S.A. Reservoir, reservoir filling method and device for dispensing fluid contained in the reservoir
US6938798B2 (en) 2000-12-08 2005-09-06 Tebro S.A. Fluid or powdery product dispensing device
US20050001411A1 (en) 2001-09-06 2005-01-06 Christian Theiss Method for the determination of parameters of a seat passenger
US7722566B2 (en) 2003-10-09 2010-05-25 Shin Nippon Biomedical Laboratories, Ltd. Device to deliver a powdery medicine into nasal cavity
WO2010142696A1 (en) 2009-06-11 2010-12-16 Charité - Universitätsmedizin Berlin Use of opioid receptor antagonists for acute treatment of paraphilic arousal states
US20110045088A1 (en) 2009-07-31 2011-02-24 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2014004400A2 (en) 2012-06-28 2014-01-03 The Governt. Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services Nasal dry powder delivery system for vaccines and other treatment agents
US9724713B2 (en) 2013-07-05 2017-08-08 Aptar France Sas Fluid or powdery product dispensing device
US20180092839A1 (en) 2016-10-03 2018-04-05 Lance L. Gooberman Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders
WO2019038756A1 (en) 2017-08-20 2019-02-28 Solubest Ltd. Dry powder compositions for intranasal delivery

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
"Aulton's Pharmaceutics: The Design and Manufacture of Medicines", 2013, ELSEVIER
"Pharmaceutical Dosage Forms: Tablets", vol. 1, 2008, CRC PRESS
"Remington: The Science and Practice of Pharmacy", 2006, UNIVERSITY OF THE SCIENCES IN PHILADELPHIA
"The HLB System: A Time-Saving Guide to Emulsifier Selection", 1976, ICI AMERICAS INC, pages: 20 - 21
BERTAN ET AL., EUR. J. PHARM. SCI., vol. 27, 2006, pages 62
GANDHI, ADVANCED DRUG DELIVERY REVIEWS, vol. 43, 1994, pages 67
J. DRUG DELIVERY, 2018, pages 1 - 19
LACHMAN ET AL.: "The Theory and Practice of Industrial Pharmacy", 1986, LEA & FEBIGER
MARTINDALE: "The Complete Drug Reference", 2014, PHARMACEUTICAL PRESS
RUSSO ET AL., J. PHARM. SCI., vol. 95, 2006, pages 2253
SHOJAEL, J. PHARM. PHARMACEUTICAL SCI., vol. 15, 1998, pages 19
VENGEROVICH ET AL., BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, vol. 163, 2017, pages 737

Similar Documents

Publication Publication Date Title
GB202019241D0 (en) Pharmaceutical composition
IL304290A (en) Pharmaceutical composition
GB201911517D0 (en) Pharmaceutical composition
FI3908321T3 (en) Pharmaceutical composition
GB202117005D0 (en) New pharmaceutical composition
GB202117007D0 (en) New pharmaceutical composition
GB202117015D0 (en) New pharmaceutical composition
GB202018901D0 (en) New pharmaceutical composition
GB202009905D0 (en) New pharmaceutical composition
GB202007328D0 (en) New pharmaceutical composition
GB202007306D0 (en) New pharmaceutical composition
GB202208464D0 (en) Pharmaceutical composition
GB202109271D0 (en) Pharmaceutical composition
GB202108387D0 (en) Pharmaceutical composition
GB202107518D0 (en) Pharmaceutical composition
GB202105858D0 (en) Pharmaceutical composition
GB202105462D0 (en) Pharmaceutical composition
GB202105047D0 (en) Pharmaceutical composition
GB202105049D0 (en) Pharmaceutical composition
GB202104224D0 (en) Pharmaceutical composition
GB202102095D0 (en) Pharmaceutical composition
GB202102100D0 (en) Pharmaceutical composition
GB202101634D0 (en) Pharmaceutical composition
GB202101640D0 (en) Pharmaceutical composition
GB202101638D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)